Tuesday, February 23, 2010

New Melanoma Drug Shows Promise

The New York Times reports on the Phase 1 clinical trial results of the new melanoma drug PLX4032. This drug specifically inhibits BRAF, a gene often mutated in advanced melanoma cancer. Read the full story here:


No comments:

Post a Comment